Ultima Genomics, Inc., a developer of ultra-high-throughput sequencing systems, continues its mission to enable sequencing at scale with the unveiling of the UG200 Series and next generation Solaris 2 ...
The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing (NGS) methods in nonclinical studies to assess the safety risks associated ...
NTRA launches Zenith genomics, a whole genome sequencing assay with MyOme to improve rare disease detection. NTRA will distribute the assay nationwide using its EMR integrations, support systems and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results